Actively Recruiting

Age: 1Year - 39Years
All Genders
NCT05096923

UNC Childhood, Adolescent, and Young Adult Cancer Cohort

Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2026-05-12

500

Participants Needed

1

Research Sites

523 weeks

Total Duration

On this page

Sponsors

U

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

H

Hyundai Hope On Wheels

Collaborating Sponsor

AI-Summary

What this Trial Is About

Purpose: This study aims to create a registry of childhood, adolescent, and young adult patients with cancer (\<40 years-old at cancer diagnosis), entitled the 'UNC Childhood, Adolescent, and Young Adult Cancer Cohort' (UNC-CAYACC). This resource will serve to support cancer outcomes research among pediatric and young adult cancer patients with a primary focus on enrolling patients treated as adolescents or young adults (AYAs, 15-39 years). Procedures: As appropriate for age, participants will complete physical and cognitive functional assessments; questionnaires to assess health-related quality of life and other patient-reported outcomes; will undergo body composition and anthropometric measurements; and will be asked to provide biospecimens for biobanking. Assessments will be collected (as possible) at diagnosis, during active treatment, following treatment completion, and annually in survivorship to assess outcomes throughout the treatment and survivorship trajectory. Sociodemographic and clinical information such as cancer treatment modalities and cumulative doses will be collected by medical record abstraction. Participants will be eligible to enroll at any time from diagnosis through survivorship. This registry will provide data to better understand the manifestations of accelerated aging and key contributing factors among children, adolescents, and young adults with cancer.

CONDITIONS

Official Title

UNC Childhood, Adolescent, and Young Adult Cancer Cohort

Who Can Participate

Age: 1Year - 39Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient ages 0-39 years at the time of cancer diagnosis (ages 1-39 years at enrollment) who are at any point in treatment and survivorship trajectory
  • English or Spanish speaking
Not Eligible

You will not qualify if you...

  • Unwilling to sign informed consent
  • Speak a language other than English or Spanish.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

Loading map...

Research Team

A

Andrew Smitherman, MD

CONTACT

L

Lauren Lux, MSW

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here